section name header

Y-Site Injection Compatibility (1:1 Mixture)

Lorazepam

(Mfr: HOS)(Conc: 1 mg/mLn)

I

Cefiderocol sulfate tosylate

(Mfr: SHI)(Conc: 20 mg/mLn)

Remarks:

Results of subvisual tests indicate lightly hazy to hazy solutions with or without increased turbidity and a high count of particles =2 µm

Ref:

3662